Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 21, 2013Acetylcysteine Ophthalmic SolutionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-857-2013Class IITerminatedAug 14, 2013Zolpidem Tartrate Tablets 5 mgUnit Dose Mispackaging: This recall event is due to a random undetected packaging issue which could increase the potential for a small number of individual unit dose...American Health Packaging · D-856-2013Class IIITerminatedAug 14, 2013BuPROPion Hydrochloride Extended-Release TabletsFailed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.Actavis Inc · D-855-2013Class IIITerminatedAug 14, 2013IntrovaleContraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily...Sandoz Incorporated · D-854-2013Class IITerminatedAug 14, 2013Lisinopril TabletsFailed Impurities/Degradation Specifications: Out of Specification results for Individual Other Unknown Related Compounds were obtained at the 48 month time-point.West-Ward Pharmaceutical Corp. · D-853-2013Class IITerminatedAug 14, 2013Latanoprost Ophthalmic SolutionLack of Assurance of Sterility: Failed at expiry for Preservative Effectiveness Test (PET), therefore the product may be susceptible to microbial growth before the...Apotex Inc · D-852-2013Class IITerminatedAug 14, 2013Ondansetron InjectionPresence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lotHospira, Inc. · D-851-2013Class IIITerminatedAug 14, 2013TUMS, Antacid/Calcium SupplementPresence of Foreign Tablets/Capsules: Product labeled TUMS Ultra Assorted Berries 1000mg Chewable tables, may contain EX TUMS Assorted Berries 750mg tabletsGlaxoSmithKline, LLC. · D-850-2013Class IITerminatedAug 14, 2013Methylphenidate Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.Teva Pharmaceuticals USA, Inc. · D-849-2013Class IITerminatedAug 14, 2013Methylphenidate Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.Teva Pharmaceuticals USA, Inc. · D-848-2013Class IITerminatedAug 14, 2013Methylphenidate Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.Teva Pharmaceuticals USA, Inc. · D-847-2013Class IITerminatedAug 14, 2013Parsel PlusDefective container: products are packaged in pouches which may not have been fully sealedNovartis Consumer Health · D-846-2013Class IITerminatedAug 14, 2013No Doz, Max StrengthDefective container: products are packaged in pouches which may not have been fully sealedNovartis Consumer Health · D-845-2013Class IITerminatedAug 14, 2013Excedrin MigraineDefective container: products are packaged in pouches which may not have been fully sealedNovartis Consumer Health · D-844-2013Class IITerminatedAug 14, 2013Excedrin Extra StrengthDefective container: products are packaged in pouches which may not have been fully sealedNovartis Consumer Health · D-843-2013Class IITerminatedAug 14, 2013Terazosin Hydrochloride CapsulesLabeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg CapsulesTeva Pharmaceuticals USA, Inc. · D-842-2013Class IITerminatedAug 14, 2013Rifadin, Rifampin capsulesSubpotent drug: low fill volume in some of the capsulesSanofi US · D-841-2013Class IITerminatedAug 14, 2013MERREM I.VPresence of Precipitate; potential for incomplete constitution upon addition of diluent.AstraZeneca Pharmaceuticals LP · D-840-2013Class IITerminatedAug 14, 2013VersaPharm IncorporatedDiscoloration: Ethambutol HCl Tablets 400 mg is being recalled due to a Out of Specification result for description testing for a surface defect of ink.West-Ward Pharmaceutical Corp. · D-839-2013Class ITerminatedAug 14, 2013Warfarin Sodium TabletsFailed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.Zydus Pharmaceuticals USA Inc · D-838-2013Class ITerminatedAug 14, 2013Reumofan PlusMarketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.Reumofan Plus USA · D-837-2013Class ITerminatedAug 14, 20130.9% Sodium Chloride InjectionPresence of Particulate Matter: reports of small grey/brown particles found in the primary container identified as brass particulatesHospira Inc. · D-836-2013Class ITerminatedAug 14, 2013Piperacillin and Tazobactam for InjectionCrystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.Apotex Corp. · D-835-2013Class ITerminatedAug 14, 2013Lightning ROD capsulesMarketed Without An Approved NDA/ANDA: Lightning Rod capsules are being recalled because FDA analysis found it to contain an undeclared analogue of sildenafil...Chang Kwung Products · D-834-2013Class ITerminatedAug 14, 2013Lightning ROD capsulesMarketed Without An Approved NDA/ANDA: Lightning Rod capsules are being recalled because FDA analysis found it to contain an undeclared analogue of sildenafil...Chang Kwung Products · D-833-2013Class ITerminatedAug 14, 2013Methotrexate InjectionPresence of Particulate Matter: Found during examination of retention samples.Sandoz Incorporated · D-832-2013Class IITerminatedAug 7, 2013DIANEAL Low CalciumDefective Container: There is a potential for frangible components to be broken, resulting in a leak at the port when the closure is removed.Baxter Healthcare Corp. · D-831-2013Class IITerminatedAug 7, 2013Olanzapine TabletsDefective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or...Torrent Pharma Inc · D-830-2013Class IITerminatedAug 7, 2013Ranitidine SyrupFailed Impurity/Degradation Specification; "Related Compound C"Actavis South Atlantic LLC · D-829-2013Class ITerminatedAug 7, 2013Night Bullet CapsulesMarketed Without an Approved NDA/ANDA; product contains analogues of sildenafil and tadalafil which are active pharmaceutical ingredients in FDA-approved drugs used to...Green Planet Inc · D-828-2013Class IITerminatedAug 7, 2013DayQuil Sinex DayTime Sinus ReliefUnit Dose Mispackaging: Product packaging defect which could result in code date smearing, incomplete blister card cuts, and missing or incorrectly placed liquicaps...Procter & Gamble Co · D-827-2013Class IITerminatedAug 7, 2013Belladonna Alkaloids/PBPresence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager...Physicians Total Care, Inc. · D-826-2013Class IITerminatedAug 7, 2013EnablexFailed Impurities/Degradation Specifications: unspecified degradation productWarner Chilcott US LLC · D-822-2013Class IITerminatedJul 31, 2013West-ward Belladonna Alkaloids with Phenobarbital TabletsCross contamination with other products: Belladonna Alkaloids with Phenobarbital Tablets contained a trace amount of Methocarbamol.West-Ward Pharmaceutical Corp. · D-825-2013Class IITerminatedJul 31, 2013West-ward Belladonna Alkaloids with Phenobarbital TabletsPresence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets.West-Ward Pharmaceutical Corp. · D-824-2013Class IIITerminatedJul 31, 2013Oxycodone and Acetaminophen CapsulesSubpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry...Watson Laboratories Inc · D-823-2013Class IITerminatedJul 31, 2013AmBisomeLack of Sterility Assurance; During a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in some media fill units. No...Gilead Sciences, Inc. · D-821-2013Class IITerminatedJul 31, 2013AmBisomeLack of Assurance of Sterility; Astellas Pharma US, Inc. is performing a voluntary recall on certain lots of AmBisome because the manufacturer has notified Astellas that...Astellas Pharma US Inc · D-820-2013Class IITerminatedJul 31, 2013VIVITROLLack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.Alkermes, Inc. · D-819-2013Class IITerminatedJul 31, 2013Oxygen, Compressed USP UN1072 Medical Gas supplied in a) 682 litres and b)165 litres cylindersFailed impurities/degradation specifications: Purity readings for oxygen were out of specification.Oklahoma Respiratory Care Inc · D-818-2013